Acting FDA Commissioner Janet Woodcock, in a letter to HHS' Office of the Inspector General on Friday, called for an investigation into the approval process of Biogen's new Alzheimer's drug, Aduhelm. A Biogen spokesperson said in response to the news that the company would "cooperate with any inquiry in connection with a possible review of the regulatory process."
Amazon Care—Amazon's medical care service—has approached Aetna and other health insurers to discuss including Amazon Care in their networks as a covered benefit. Conversations on what the payment structure would look like are ongoing, according to several sources close to the matter.
Moderna last week announced it began testing its first seasonal flu vaccine, which uses the same mRNA technology the company used to develop its Covid-19 vaccine. According to Moderna CEO Stéphane Bancel, the trial is part of a larger effort to develop a combination vaccine that would target "the most problematic respiratory viruses."